The Radiopharmaceutical Fork in the Road: Radioantibodies versus Radioligands

Time: 2:30 pm
day: Day One - PM

Details:

  • Does the success of Lutathera and Pluvicto foretell a wave of effective Radioligands
  • Paradoxical advantages/disadvantages of ligands and antibodies
  • Blending Radioantibodies and Radioligands: the ideal Radiopharmaceutical approach

Speakers:

Neil Bander Dr. Neil H. Bander is the former Bernard and Josephine Chaus Professor of Urologic Oncology and current Professor Emeritus of Urology at Weill Cornell Medicine. Read more